Sign in

CIK 0001737953

  • Non-accelerated filer
  • Smaller reporting company

Replimune Group, Inc.

Sign in to watch
Ticker
REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
822082553
Phone
+1 781-222-9600
Business address
500 UNICORN PARK, WOBURN, MA, 01801
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$521,860
in 2 filings

Net −$521,860. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Dhingra Kapil −$409K Director sold 50% of stake
  2. SLATTERY JOSEPH P −$113K Director sold 78% of stake

Reading 83 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-05-16 Coffin Robert President & Chief R&D Officer Sale −5,737 $14.59 $84K 1,796,197
2022-05-16 Astley-Sparke Philip Chief Executive Officer Sale −9,632 $14.59 $141K 1,401,080
2022-04-01 Astley-Sparke Philip Chief Executive Officer Grant or award +70,000 1,410,712
2022-04-01 Astley-Sparke Philip Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +105,000 105,000
2022-04-01 Coffin Robert President & Chief R&D Officer Grant or award +26,250 1,801,934
2022-04-01 Coffin Robert President & Chief R&D Officer Grant or award · Employee Stock Option (right to buy) +39,375 39,375
2022-04-01 Franchi Jean M. Chief Financial Officer Grant or award +52,500 98,535
2022-04-01 Franchi Jean M. Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +78,750 78,750
2022-04-01 Patel Sushil Chief Commercial Officer Grant or award +52,500 140,833
2022-04-01 Patel Sushil Chief Commercial Officer Grant or award · Employee Stock Option (right to buy) +78,750 78,750
2022-04-01 Lewis Tanya Chief Dev.Op Off Grant or award +52,500 125,833
2022-04-01 Lewis Tanya Chief Dev.Op Off Grant or award · Employee Stock Option (right to buy) +78,750 78,750
2022-04-01 Esposito Pamela Chief Business Officer Grant or award +22,750 232,909
2022-04-01 Esposito Pamela Chief Business Officer Grant or award · Employee Stock Option (right to buy) +34,125 34,125
2022-04-01 Love Colin Chief Operating Officer Grant or award +26,250 772,059
2022-04-01 Love Colin Chief Operating Officer Grant or award · Employee Stock Option (right to buy) +39,375 39,375
2022-04-01 Rhodes Jason P Director Grant or award · Stock Option (right to buy) +16,500 16,500
2022-04-01 Dhingra Kapil Director Grant or award · Stock Option (right to buy) +16,500 16,500
2022-04-01 SLATTERY JOSEPH P Director Grant or award · Stock Option (right to buy) +16,500 16,500
2022-04-01 Weinand Dieter Director Grant or award · Stock Option (right to buy) +24,750 24,750

Page 10 of 19 · 365 trades